Abstract:Objective To investigate the effects of fenofibrate (FF), a peroxisome proliferator- activator receptor α (PPAR-α) activator on the cardiac injury caused by myocardial ischemia and mechanism thereof. Methods Forty-eight male SD rats were randomly divided into 3 equal groups: isoproterenol (ISO) group and control group both undergoing gastric lavage of normal saline (NS) 20 ml/kg once a day for 7d, and FF pretreatment group, undergoing gastric lavage of FF solved in NS 20 ml/kg once a day for 7d.One hour after the last lavage the FF and ISO groups underwent intraperitoneal injection of ISO 5 mg/kg, and the control group underwent intrapeitoneal injection of NS. 24 h later blood samples was obtained by picking out the eyeball to isolate serum. And then the hearts were taken out for measurement of heart weight (HW), pathology of the myocardium, and calculation of the HW/body weight (BW)% and infarction size (IS)/ventricular weight (VW)%. Nitrate reductase method and double antibody sandwich ELISA were used to detect the serum nitrogen oxide (NO) and tumor necrosis factor ( TNF)-α. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was used to examine the PPARα protein expression in the myocardium. Results The HW/BW of the ISO group was (6.71±0.55) mg/g, significantly higher than that of the control group [(4.05±0.37) mg/g, P<0.01], and the HW/BW of the FF group was (5.28±0.49) mg/g, significantly lower than that of the ISO group (P <0.05) and still significantly higher than that of the control group (P <0.05). The IS/VW% of the ISO group was (0.75±0.09)%, significantly higher than that of the control group [(0.07±0.02)%, P <0.01]; and the IS/VW% of the FF group was (0.31±0.08)%, significantly lower than that of the ISO group (P <0.01) and still significantly higher than that of the control group (P <0.01). The serum NO level of the ISO group was (20.79±5.95) μmol/L, significantly lower than that of the control group [(49.65±6.97)μmol/L, P <0.01], and the serum NO level of the FF group was (80.45±11.61) μmol/L, significantly higher than those of the control and ISO groups (both P <0.01). The serum TNF-α level of the ISO group was (275.41±27.61)%, significantly higher than that of the control group [(20.01±3.29)%, P <0.01]; and the serum TNF-α level of the FF group was (149.07±22.39)%, significantly lower than that of the ISO group (P <0.01), but still significantly higher than that of the control group (P <0.01). The PPARα protein expression level of the ISO group was significantly lower than that of the control group (P <0.05), and the PPARα protein expression level of the FF group was significantly higher than those of the ISO and control groups (both P <0.05). Conclusion FF reduces the cardiac infarction area and protects the heart from ischemic injury via activating PPARα.

PPARα Agonist Fenofibrate Ameliorates Learning and Memory Deficits in Rats Following Global Cerebral Ischemia

EGB1212 Post-Treatment Ameliorates Hippocampal CA1 Neuronal Death and Memory Impairment Induced by Transient Global Cerebral Ischemia/reperfusion.

Fenofibrate Increases Heme Oxygenase 1 Expression and Astrocyte Proliferation While Limits Neuronal Injury During Intracerebral Hemorrhage

The Protective Effect of Fenofibrate on Acute Focal Cerebral Ischemia Reperfusion Injury in Mice

Fenofibrate Ameliorates Hepatic Ischemia/Reperfusion Injury in Mice: Involvements of Apoptosis, Autophagy, and PPAR-α Activation

Neuroprotective Effects of Prostaglandin A(1) in Rat Models of Permanent Focal Cerebral Ischemia Are Associated with Nuclear Factor-Kappa B Inhibition and Peroxisome Proliferator-Activated Receptor-Gamma Up-Regulation

Activation of Liver X Receptor Β-Enhancing Neurogenesis Ameliorates Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion.

PPARα Agonist Fenofibrate Prevents Postoperative Cognitive Dysfunction by Enhancing Fatty Acid Oxidation in Mice

Protective effects of Fenofibrate on renal ischemia-reperfusion injury in rats

[Effects of Progesterone on Learning and Memory and P2X7 Receptor Expression in the Hippocampus after Global Cerebral Ischemia/ Reperfusion Injury in Rats].

Paeoniflorin ameliorates ischemic injury in rat brain via inhibiting cytochrome c/caspase3/HDAC4 pathway

Effects of fenofibrate on acute myocardial ischemic damage induced by isoproterenol: experiment with rats

Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2

Centrophenoxine improves chronic cerebral ischemia induced cognitive deficit and neuronal degeneration in rats

Protective Effects and Mechanism of Puerarin on Learning-Memory Disorder after Global Cerebral Ischemia-Reperfusion Injury in Rats

Activation of peroxisome proliferator-activated receptor β/δ attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats.

The synergistic ameliorative activity of peroxisome proliferator-activated receptor-alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance

Ppar Delta Agonist Gw0742 Ameliorates A Beta(1-42)-Induced Hippocampal Neurotoxicity In Mice

Protective effects of PPARγ agonist on the ischemia-reperfusion brain and the inflammation mechanisms

Neuroprotective Effects of Pioglitazone in a Rat Model of Permanent Focal Cerebral Ischemia Are Associated with Peroxisome Proliferator-Activated Receptor Gamma-Mediated Suppression of Nuclear Factor-Κb Signaling Pathway

Alpha-Lipoic Acid Preconditioning and Ischaemic Postconditioning Synergistically Protect Rats from Cerebral Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/ NF-κB Signaling Pathway.